Echelon Biosciences Inc. is pleased to join the NIH Glycoscience Common Fund Program listing of Companies w/ Glycoscience Catalogs. Echelon […]
Utah’s flourishing Life Sciences Industry was proudly on display at the 2023 Annual Life Sciences Day on Capitol Hill. Echelon
Echelon Biosciences announces partnership with ProBioscience Technologies for distribution in Southeast Asia
Echelon Biosciences Inc. (EBI) is excited to announce a new partnership with ProBioscience Technologies for product distribution in Singapore and
November, 15, 2022 – Salt Lake City, UT, USA – Echelon Biosciences announces that it has been selected as the 2022
(Salt Lake City, UT and Paris, FR, April 13, 2021) – HTL, the worldwide leader in biotechnology solutions using hyaluronic
Echelon Biosciences is proud to announce a new partnership with Biotechno Labs for product distribution in India. Based in New
Echelon Biosciences awarded DoD grant to establish a production platform for countermeasures against chemical warfare agents
A new SBIR grant through the Department of Defense aims to develop new prophylactic treatments for exposure to chemical warfare
Echelon Biosciences is now the sole authorized distributor for Select-HA™ products from Hyalose, LLC.
Spring 2019 Press Release Echelon now offers the follwing Hyalose products: Select-HA™ Select-HA™ is a hyaluronic acid (HA) preparation
Echelon Biosciences sub-awarded DoD grant to develop drugs to thwart impact of trauma, stroke, and cardiac arrest
A $2.3 million Department of Defense grant will help neuroscientists develop new treatments for the emergency room and the battlefield.